Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NPFFR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TFDP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF166 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VASH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CLYBL-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HDGFRP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC93463 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TLR6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFAP74 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC25A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C20orf141 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TACR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITPR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNF1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGFR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFATC2IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on